Funding Rounds · Series A

Accure Therapeutics — Series A · €7.6M

Accure Therapeutics, formed by merging Iproteos and Bionure, launched with a €7.6M Series A led by Alta Life Sciences and backed by CDTI. It develops drugs for central nervous system diseases such as optic neuritis, multiple sclerosis, Parkinson's and epilepsy.

LeadAlta Life Sciences RoundSeries A Announced26 May 2020 CityBarcelona SectorHealthtech & Bio · Biotech Source

Something wrong? Suggest a correction →

The company

Accure Therapeutics
accuretherapeutics.com
Series A Barcelona

Investors 2

Alta Life Sciences
www.altals.com
LeadSpain
CDTI
www.cdti.es
Profile: Centro para el Desarrollo Tecnológico y la Innovación
Spain

← All funding rounds

Start typing to search across everything.
↑↓ navigate↵ openesc close? shortcuts
Keyboard shortcuts
/ Ctrl K
Search
j k
Next or previous row
↵
Open the row
Ctrl ↵
Open it in a new tab
[ ]
Previous or next page
?
This list